Vaccines Clinical Trials
Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.
VAX-31A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
Sponsor:
Vaxcyte, Inc.
Location:
Code:
NCT06720038
Conditions
Pneumococcal Vaccines
Eligibility Criteria
Sex: All
Age: 42 - 70+
Healthy Volunteers: Accepted
Interventions
0.5 mL of the low dose VAX-31
0.5 mL of the mid dose VAX-31
0.5 mL of the high dose VAX-31
0.5 mL dose of PCV20
HPV VaccineReMARK: Addressing Disparities in Rural Communities to Increase the HPV Vaccine Recommendation Effectiveness
Sponsor:
University of Florida
Location:
Code:
NCT06535139
Conditions
Papillomavirus Vaccines
Eligibility Criteria
Sex: All
Age: 8 - 70+
Healthy Volunteers: Not accepted
Interventions
Brief training
Parent-targeted motivational aids
Healthcare access
Vaccine ResponsesVaccine Responses in Cancer
Sponsor:
Abramson Cancer Center at Penn Medicine
Location:
Code:
NCT06605625
Conditions
Viral Vaccines
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Influenza vaccination
SARS-CoV-2 vaccine
Zoster Vaccine Recombinant
Personalized FeedbackTesting a Personalized Normative Feedback Intervention for Vaccine Hesitancy
Sponsor:
University of Washington
Location:
Code:
NCT05787015
Conditions
COVID-19
Vaccine Hesitancy
Eligibility Criteria
Sex: All
Age: 18 - 24
Healthy Volunteers: Accepted
Interventions
Vaccine Norms Feedback
Alcohol Norms Feedback
MMRV VaccineIs a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?
Sponsor:
University of Alberta
Location:
Code:
NCT05923970
Conditions
Vaccination Failure
Vaccine Response Impaired
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Serology for antibody levels - Baseline
Serology to assess cell mediated immune (CMI) response - Baseline
Serology for antibody levels - Post third dose of MMR vaccine
Serology to assess CMI - Post third dose of MMR vaccine
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ThymalfasinThymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine
Sponsor:
The Methodist Hospital Research Institute
Location:
Code:
NCT06821100
Conditions
Vaccine Response
COVID-19 Vaccine
Immune Response to Covid 19 Vaccination
Eligibility Criteria
Sex: All
Age: 65 - 70+
Healthy Volunteers: Accepted
Interventions
Thymalfasin (Thymosin alpha 1, Ta1)
CHW InterventionA CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination
Sponsor:
Charles Drew University of Medicine and Science
Location:
Code:
NCT05473936
Conditions
Vaccine Hesitancy
COVID-19 Testing
Community Health Workers
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Accepted
Interventions
Community Health Worker led curriculum
Tdap AcceptanceAssessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Sponsor:
Women and Infants Hospital of Rhode Island
Location:
Code:
NCT06135636
Conditions
Non-birthing Partner Vaccination in Pregnancy
Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination
Vaccine Exposure During Pregnancy
Eligibility Criteria
Sex: All
Age: 19 - 50
Healthy Volunteers: Accepted
Interventions
Education
Vaccine administration
Herpes Zoster VaccineA Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
Sponsor:
Beijing Luzhu Biotechnology Co., Ltd.
Location:
Code:
NCT05750017
Conditions
Herpes Zoster
Vaccine-Preventable Diseases
Eligibility Criteria
Sex: All
Age: 50 - 70
Healthy Volunteers: Accepted
Interventions
Low Dose Recombinant Herpes Zoster Vaccine (LZ901)
High Dose Recombinant Herpes Zoster Vaccine (LZ901)
Placebo
What are vaccine clinical trials?
Vaccine clinical trials are research studies conducted to evaluate the safety, efficacy, and immunogenicity (the ability to provoke an immune response) of vaccines aimed at preventing diseases. These trials are crucial for developing new vaccines against various conditions, including infectious diseases, cancers, and chronic conditions.
Importance of clinical trials for vaccines
Clinical trials for vaccines play a vital role in ensuring that new vaccines are both safe and effective before they are made available to the public. These trials help identify the best dosing schedules, understand how the immune system responds to the vaccine, and determine any potential side effects. They are fundamental in the fight against emerging infectious diseases, as well as in the development of therapeutic vaccines for conditions like cancer.
Types of interventions studied in vaccine clinical trials
Vaccine clinical trials investigate a wide array of vaccines. These interventions aim to stimulate the immune system to produce a protective response against specific pathogens. Some common types of interventions studied in vaccine clinical trials include:
Preventive vaccines
These trials focus on vaccines designed to prevent infectious diseases, such as the COVID-19 vaccine, the Western Equine Encephalitis (WEE) vaccine, and vaccines against Respiratory Syncytial Virus (RSV).
Therapeutic vaccines
Some trials study vaccines intended to treat existing conditions, such as vaccines targeting ovarian cancer, follicular lymphoma, and pancreatic cancer. These vaccines aim to stimulate the immune system to attack cancer cells.
Combination vaccine trials
These studies explore the safety and efficacy of combining different vaccines, such as measles, mumps, rubella, and chickenpox vaccines, to improve immunity with fewer injections.
Eligibility and participation in vaccine clinical trials
Eligibility for vaccine clinical trials varies depending on the study's focus. Trials may be open to specific age groups, genders, and health conditions. Both healthy volunteers and those with the condition being targeted by the vaccine may be eligible to participate. Criteria often include age, health status, and history of vaccination.
What to expect when participating in a vaccine clinical trial
Participants can expect to undergo initial screenings to determine eligibility, receive detailed information about the study, and be monitored for their response to the vaccine and any side effects. Trials may involve receiving the investigational vaccine or a placebo and attending follow-up appointments to assess health outcomes.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
How to enroll in a vaccine clinical trial
Enrolling in a clinical trial for vaccines through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our search bar or filters to find clinical trials for vaccines that match your interests and needs. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location:To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.